Sanofi SA (SAN)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account
Sell

€91.75

Buy

€91.77

arrow-up€1.90 (+2.11%)

Sanofi SA is healthcare company which is engaged in the research, development, manufacture and marketing of therapeutic solutions. It business activities include operations of specialty care, Established Prescription Products and vaccines operations.
Prices updated at 16 May 2025, 11:51 BST
| Prices minimum 15 mins delay
|
Prices in EUR
Sector
Healthcare
Industry
Drug Manufacturers - General
Chairman
Mr. Frederic Oudea
CEO
Mr. Paul Hudson
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
82,878
Head office
46, Avenue de la Great Army
Paris
France
75017
mobile
+33 153774000
letter
investor.relations@sanofi.com

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Francois-Xavier Roger
Executive Vice President and Chief Financial Officer
-----
Ms. Lise Kingo
Independent Director
0.17m--0.17m-
Mr. Olivier Charmeil
Executive Vice President, General Medicines
-----
Mr. Paul Hudson
Director and Chief Executive Officer
1.30m4.23m-5.53m-
Ms. Fabienne Lecorvaisier
Independent Director
0.17m--0.17m-
Mr. Patrick Kron
Independent Director
0.20m--0.20m-
Mr. Frederic Oudea
Chairman of the Board
-----
Ms. Anne-Francoise Nesmes
Independent Director
0.12m--0.12m-
Mr. Jean-Paul Kress
Independent Director
-----
Mr. Christophe Babule
Director
0.16m--0.16m-
Mr. John Sundy
Independent Director
0.11m--0.11m-
Ms. Rachel Duan
Independent Director
0.15m--0.15m-
Ms. Carole Ferrand
Independent Director
0.20m--0.20m-
Dr. Antoine Yver, M.D.,M.Sc.
Independent Director
0.18m--0.18m-
Ms. Natalie Bickford
Executive Vice President and Chief People Officer
-----
Ms. Julie Van Ongevalle
Executive Vice President, Consumer Healthcare
-----
Mr. Thomas Triomphe
Executive Vice President, Vaccines
-----
Ms. Clotilde Delbos
Independent Director
0.12m--0.12m-
Mr. Brendan O'Callaghan
Executive Vice President, Global Manufacturing & Supply
-----
Mr. Roy Papatheodorou
Executive Vice President and General Counsel
-----
Mr. Wolfgang Laux
Director
0.13m--0.13m-
Ms. Barbara Lavernos
Director
0.16m--0.16m-
Mr. Yann Tran
Director
0.11m--0.11m-
Mr. Emile Voest
Independent Director
0.16m--0.16m-
Ms. Madeleine Roach
Executive Vice President, Business Operations
-----
Mr. Emmanuel Frenehard
Executive Vice President and Chief Digital Officer
-----
Mr. Brian Foard
Executive Vice President, Specialty Care
-----
Mr. Houman Ashrafian
Executive Vice President and Head of Research and Development
-----
Ms. Audrey Duval
Executive Vice President, Corporate Affairs
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Capital Research and Management Company49,407,62424.465777927824-30 Apr 20254.05
Vanguard Group Inc32,576,8128.62527547088-30 Apr 20252.67
BlackRock Fund Advisors22,482,05035.38174413798-30 Apr 20251.84
Dodge & Cox19,170,9048.71028-227700-30 Apr 20251.57
Capital Group15,590,3384.568393854243-30 Apr 20251.28

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
No data
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.